Literature DB >> 18300124

A defective angiogenesis in chronic kidney disease.

Narisa Futrakul1, Punnee Butthep, Narumon Laohareungpanya, Papada Chaisuriya, Kavi Ratanabanangkoon.   

Abstract

BACKGROUND: A progressive reduction in peritubular capillary flow is observed in chronic kidney disease (CKD) patients as the disease severity progresses. This suggests an altered vascular homeostasis in CKD patients, but such a defective mechanism needs to be verified.
METHODS: To study the vascular injury as reflected by circulating endothelial cell (CEC), the balance between angiogenic factor, vascular endothelial growth factor (VEGF), and antiangiogenic factor, endostatin.
RESULTS: A deficient VEGF was observed, whereas the value of endostatin and CEC were abnormally elevated in CKD patients. DISCUSSION: Enhanced CEC reflects an increased activity of vascular injury. A deficient VEGF in the presence of enhanced antiangiogenesis (endostatin) implies a defective angiogenesis. This may explain the progressive nature of renal microvascular disease observed in late stage of CKD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300124     DOI: 10.1080/08860220701813335

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  22 in total

1.  Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization.

Authors:  Erika Guise; Jason E Engel; Maxx L Williams; Fakhri Mahdi; Gene L Bidwell; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-20

Review 2.  VEGF therapy for the kidney: emerging strategies.

Authors:  Erika Guise; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2018-02-14

3.  Elevated plasma levels of endostatin are associated with chronic kidney disease.

Authors:  Jing Chen; L Lee Hamm; Myra A Kleinpeter; Fred Husserl; Islam Enver Khan; Chung-Shiuan Chen; Yanxi Liu; Katherine T Mills; Chuan He; Nader Rifai; Eric E Simon; Jiang He
Journal:  Am J Nephrol       Date:  2012-03-27       Impact factor: 3.754

4.  Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis.

Authors:  Alejandro R Chade
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-09       Impact factor: 3.619

Review 5.  Endostatin in Renal and Cardiovascular Diseases.

Authors:  Mei Li; Zoran Popovic; Chang Chu; Bernhard K Krämer; Berthold Hocher
Journal:  Kidney Dis (Basel)       Date:  2021-09-09

Review 6.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

Review 7.  Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

Authors:  Alejandro R Chade; Nicholas Stewart
Journal:  J Am Soc Hypertens       Date:  2013-02-19

Review 8.  Renal vascular structure and rarefaction.

Authors:  Alejandro R Chade
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

Review 9.  Inflammation and Oxidative Damage in Ischaemic Renal Disease.

Authors:  Áine M de Bhailís; Constantina Chrysochou; Philip A Kalra
Journal:  Antioxidants (Basel)       Date:  2021-05-25

10.  Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis.

Authors:  Rukshana C Shroff; Karen L Price; Maria Kolatsi-Joannou; Alexandra F Todd; David Wells; John Deanfield; Richard J Johnson; Lesley Rees; Adrian S Woolf; David A Long
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.